Zacks Research Boosts Earnings Estimates for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY) – Equities research analysts at Zacks Research lifted their FY2025 EPS estimates for shares of HealthEquity in a research report issued to clients and investors on Monday, December 30th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $2.30 for the year, up from their prior estimate of $2.25. The consensus estimate for HealthEquity’s current full-year earnings is $3.12 per share.

Several other equities research analysts have also commented on the stock. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Bank of America raised their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. Finally, Barrington Research boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Stock Down 0.9 %

NASDAQ:HQY opened at $95.95 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 4.10. The company’s fifty day moving average price is $96.51 and its 200-day moving average price is $85.30. HealthEquity has a 1-year low of $65.01 and a 1-year high of $105.82. The firm has a market capitalization of $8.32 billion, a P/E ratio of 88.03, a PEG ratio of 1.08 and a beta of 0.55.

Insider Buying and Selling

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,539 shares of company stock worth $4,040,303. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Hedge funds have recently modified their holdings of the company. Raymond James Trust N.A. boosted its holdings in HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares during the last quarter. Truist Financial Corp lifted its holdings in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares during the last quarter. Elk River Wealth Management LLC grew its position in HealthEquity by 0.3% in the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after acquiring an additional 217 shares during the period. Nicolet Advisory Services LLC increased its stake in HealthEquity by 5.8% during the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after acquiring an additional 233 shares during the last quarter. Finally, Sequoia Financial Advisors LLC raised its position in HealthEquity by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company’s stock valued at $1,090,000 after purchasing an additional 303 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.